MENU
SCNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SCNX stock forecast, quote, news & analysis

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company... Show more

SCNX
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for SCNX with price predictions
Sep 23, 2026

SCNX's RSI Oscillator sits in oversold zone for 8 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +0.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCNX advanced for three days, in 171 of 209 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

SCNX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCNX as a result. In 71 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for SCNX turned negative on August 25, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 41 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

SCNX moved below its 50-day moving average on August 31, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SCNX crossed bearishly below the 50-day moving average on September 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCNX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for SCNX entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.183) is normal, around the industry mean (1.257). P/E Ratio (0.556) is within average values for comparable stocks, (112.102). SCNX's Projected Growth (PEG Ratio) (0.480) is slightly lower than the industry average of (0.947). Dividend Yield (0.000) settles around the average of (0.021) among similar stocks. SCNX's P/S Ratio (11.779) is slightly higher than the industry average of (2.504).

The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. SCNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

A.I.Advisor
published Dividends

SCNX paid dividends on July 24, 2024

Scienture Holdings Inc SCNX Stock Dividends
А quarterly dividend of $1.50 per share was paid with a record date of July 24, 2024, and an ex-dividend date of July 19, 2024. Read more...
A.I.Advisor
published Highlights

Industry description

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

Market Cap

The average market capitalization across the Drugstore Chains Industry is 60.59M. The market cap for tickers in the group ranges from 36.55K to 14.75B. JDHIF holds the highest valuation in this group at 14.75B. The lowest valued company is PNPL at 36.55K.

High and low price notable news

The average weekly price growth across all stocks in the Drugstore Chains Industry was -2%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -42%. POM experienced the highest price growth at 2%, while SCNX experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Drugstore Chains Industry was -36%. For the same stocks of the Industry, the average monthly volume growth was 114% and the average quarterly volume growth was -68%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 89
Price Growth Rating: 73
SMR Rating: 82
Profit Risk Rating: 100
Seasonality Score: -10 (-100 ... +100)
View a ticker or compare two or three
SCNX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of an online platform for pharmaceutical purchasers

Industry DrugstoreChains

Industry
N/A
Address
20 Austin Boulevard
Phone
+1 631 670-6039
Employees
9
Web
https://www.scienture.com
SCNX's RSI Oscillator sits in oversold zone for 8 days